HOME >> MEDICINE >> NEWS
International breast cancer prevention study launches in the United States and Canada

Boston-March 30, 2005 Today, a new clinical trial evaluating a novel approach to breast cancer prevention launched in the United States and Canada. Called the ExCel research study, this is the first North American clinical trial to evaluate the role of an aromatase inhibitor in the prevention of breast cancer.

Coordinated by the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), the ExCel research study will examine the potential benefit of exemestane and its ability to prevent breast cancer in women who are at increased risk for the disease. Exemestane part of a class of drugs called aromatase inhibitors suppresses estrogen production, a key component in the development of some types of breast cancer. Exemestane could provide women with an alternative option to tamoxifen, the only drug FDA approved for prevention of breast cancer.

"Breast cancer is a major public health issue every 30 seconds somewhere in the world a woman is diagnosed with this disease," says Dr. Paul Goss, the ExCel research study chair.

"Thousands of women have already beat breast cancer thanks to recent research on aromatase inhibitors. As a result, we think this could be an effective approach to preventing it from developing in the first place."

The ExCel research study will follow more than 4,500 postmenopausal women from the U.S., Canada and Spain over a five year period. To be eligible, women must be 35 years of age or older and have an increased risk of developing breast cancer. Risk factors can include a woman's age, her family history of breast cancer, her age at first menstrual period and her age at first live birth.

Initial results of the trial could be available within four years and study investigators hope to see as much as a two-thirds reduction in the incidence of breast cancer among women in the treatment group.

Aromatase inhibitors are currently being used to treat breast cancer in wo
'"/>

Contact: Samantha Kaplan
samantha.kaplan@edelman.com
312-297-7439
Edelman Public Relations
30-Mar-2005


Page: 1 2 3 4

Related medicine news :

1. National Academies advisory: May 2 Symposium on International Science Policy
2. Awards & fellowships at the International & American Association for Dental Research General Session
3. Lectures, keynoters, symposia highlight International Dental Research meeting
4. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
5. International gathering of experts to share retinoblastoma breakthroughs
6. International trial of two microbicides begins
7. International gathering at UH examines top computer code
8. International trial finds benefits of breast MRI in women at high risk
9. International study provides culture-by-culture clues to family violence and abuse
10. St. Jude scientist wins International Society of Experimental Hematology award
11. International MRC trial finds a routine treatment for head injury may do more harm than good

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... ... economic outlook continues to put financial strain on many of us, so it just makes ... monthly expenses and put more into savings, if possible. , “That’s a great way to ... in place in case something were to happen to you,” says Lee Duncan, CMO & ...
(Date:8/31/2020)... ... August 31, 2020 , ... In an effort to give back ... donating 10 percent of each hotel room booked with a special new rate code ... Northwest Indiana (RMHC-CNI) , effective immediately. Donations will be applied to any room ...
(Date:8/31/2020)... ... August 31, 2020 , ... Bonde Innovations, LLC, ... with advanced heart failure, today announced that the company has been awarded a ... from the National Heart, Lung, and Blood Institute of the National Institutes of ...
(Date:8/28/2020)... ... 28, 2020 , ... Ernst & Young LLP (EY US) ... Of The Year® 2020 Florida Award finalist. Now in its 34th year, the ... growth and prosperity as they build and sustain successful businesses that transform our ...
(Date:8/28/2020)... ... August 28, 2020 , ... The 15 scholarships being offered ... & Wellness mobile app and web-portal. NCPCV received a 2020 grant from Motorola ... each year to organizations, such as Destination Imagination, which support and advance public ...
Breaking Medicine News(10 mins):
(Date:8/26/2020)... ... August 26, 2020 , ... AseptiScope, a privately funded ... Company of the Year by MedTech Outlook. , “AseptiScope is pleased to ... first time, clinicians who wear gloves on their hands, goggles on their eyes, covers ...
(Date:8/26/2020)... ... ... As the U.S. struggles in its 6th month of fighting Covid-19, Americans ... mask, keep your distance, wash your hands. Prevention is the best tool for now. ... “How much better it is to prevent disease than to cure it.” , Part ...
(Date:8/26/2020)... ... 26, 2020 , ... NucleusHealth, LLC, a provider of market ... and Chief Executive Officer effective immediately. Dr. Vishal Verma, the previous CEO, will ... , Mr. Hooton, a seasoned business executive, joined the company in February ...
Breaking Medicine Technology:
Cached News: